Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction.

IF 1.6 4区医学 Q3 PERIPHERAL VASCULAR DISEASE

Phlebology Pub Date : 2023-02-01 DOI:10.1177/02683555221142531

Ferdi Çay, Ahmet Y Altunbulak, Yakup Özbay, Gonca Eldem, Barbaros E Çil, İbrahim Vargel, Mustafa T Kutluk, Bilgehan Yalçın, Bora Peynircioğlu

{"title":"Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction.","authors":"Ferdi Çay, Ahmet Y Altunbulak, Yakup Özbay, Gonca Eldem, Barbaros E Çil, İbrahim Vargel, Mustafa T Kutluk, Bilgehan Yalçın, Bora Peynircioğlu","doi":"10.1177/02683555221142531","DOIUrl":null,"url":null,"abstract":"Purpose: This study evaluated the results of polidocanol sclerotherapy in the treatment of venous malformations (VM) including patient satisfaction, perceived improvement, and predictors of satisfaction.Material and method: Patients with VM that underwent polidocanol foam sclerotherapy between June 2013 and July 2021 in a single center were retrospectively evaluated. Patient demographics, VM, and treatment characteristics were analyzed. Patient-reported outcomes and satisfaction were analyzed with a questionnaire.Results: This study included 232 (136, 58.6%, female) patients. The mean age was 24.49 ± 12.45 years (range 3-72). The clinical response rate was 82.3%. The rate of satisfaction was 82.3%, and 116 (50%) patients were significantly satisfied. There were no major complications. Clinical response and VM margin were related to satisfaction (p < 0.01, p = 0.012, respectively). Clinical response to pretreatment swelling was related to significant satisfaction (p = 0.02).Conclusion: Polidocanol sclerotherapy was safe and effective in VM treatment with high satisfaction and low complication rates.","PeriodicalId":20139,"journal":{"name":"Phlebology","volume":"38 1","pages":"36-43"},"PeriodicalIF":1.6000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02683555221142531","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 3

Abstract

Purpose: This study evaluated the results of polidocanol sclerotherapy in the treatment of venous malformations (VM) including patient satisfaction, perceived improvement, and predictors of satisfaction.

Material and method: Patients with VM that underwent polidocanol foam sclerotherapy between June 2013 and July 2021 in a single center were retrospectively evaluated. Patient demographics, VM, and treatment characteristics were analyzed. Patient-reported outcomes and satisfaction were analyzed with a questionnaire.

Results: This study included 232 (136, 58.6%, female) patients. The mean age was 24.49 ± 12.45 years (range 3-72). The clinical response rate was 82.3%. The rate of satisfaction was 82.3%, and 116 (50%) patients were significantly satisfied. There were no major complications. Clinical response and VM margin were related to satisfaction (p < 0.01, p = 0.012, respectively). Clinical response to pretreatment swelling was related to significant satisfaction (p = 0.02).

Conclusion: Polidocanol sclerotherapy was safe and effective in VM treatment with high satisfaction and low complication rates.

查看原文本刊更多论文

poly - canol硬化疗法治疗静脉畸形的临床效果:患者感知改善和满意度。

目的:本研究评估聚多卡因硬化疗法治疗静脉畸形(VM)的结果，包括患者满意度、感知改善和满意度预测因子。材料和方法:回顾性评估2013年6月至2021年7月在单中心接受聚多醇泡沫硬化治疗的VM患者。分析患者人口统计学、VM和治疗特征。患者报告的结果和满意度通过问卷进行分析。结果:本研究纳入232例(136例，女性58.6%)。平均年龄24.49±12.45岁(3 ~ 72岁)。临床有效率为82.3%。满意度为82.3%，其中116例(50%)患者明显满意。没有重大并发症。临床反应和VM切缘与满意度相关(p < 0.01, p = 0.012)。预处理肿胀的临床反应与满意度相关(p = 0.02)。结论:Polidocanol硬化疗法治疗VM安全有效，满意度高，并发症发生率低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phlebology 医学-外周血管病

CiteScore

3.30

自引率

11.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The leading scientific journal devoted entirely to venous disease, Phlebology is the official journal of several international societies devoted to the subject. It publishes the results of high quality studies and reviews on any factor that may influence the outcome of patients with venous disease. This journal provides authoritative information about all aspects of diseases of the veins including up to the minute reviews, original articles, and short reports on the latest treatment procedures and patient outcomes to help medical practitioners, allied health professionals and scientists stay up-to-date on developments. Print ISSN: 0268-3555